Breaking News Instant updates and real-time market news.

HIMX

Himax

$8.59

0.16 (1.90%)

15:00
10/03/16
10/03
15:00
10/03/16
15:00

Hefty call write in Himax

Hefty call write in Himax. 16.2K Dec 9 calls at 67.5c when the bid-ask was 65 to 85c. It opens a position struck 5% above spot and captures earnings in mid-November.

HIMX Himax
$8.59

0.16 (1.90%)

09/02/16
NOMU
09/02/16
NO CHANGE
Target $12
NOMU
Buy
Himax price target raised to $12 on better pricing at Nomura
Nomura analyst Donnie Teng noted that Himax has been able to raise its prices for its liquid crystal on silicon, or LCOS, and wafer level optics, or WLO, for a major augmented reality device recently, which he believes could help the company reach the higher end of its Q3 sales guidance. Teng raised his price target on Himax shares to $12 from $9.70, adding that the company plans to try to provide more cost effective LCOS and WLO products for a possible consumer AR device in 2018, which lead to higher demand. Nomura keeps a Buy rating on the stock.
09/26/16
NOMU
09/26/16
DOWNGRADE
NOMU
Neutral
Himax downgraded to Neutral from Buy at Nomura
09/28/16
ROTH
09/28/16
INITIATION
Target $10
ROTH
Buy
Himax initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Himax with a Buy and a $10 price target. Desilva believes newer HIMX products can participate in growth of IoT device categories such as augmented reality and virtual reality head-mounted devices.
09/29/16
FBCO
09/29/16
NO CHANGE
FBCO
Outperform
Himax long-term story intact, says Credit Suisse
Credit Suisse analyst Jerry Su lowered Himax's LCOS/WLO shipment assumptions for Q4-1H 2017 on slower new platform adoption following supply chain checks. Su said the 2018 AR device ramp is on track and believes Himax's long-term story on consumer AR glass and 3D sensing for smartphone remains intact, since the capacity ramp up remains on schedule. The analyst said the potential launch of consumer AR glass and 3D sensing for smartphone should boost Himax's earnings in 2018 and reiterates his Outperform rating and $14 price target.

TODAY'S FREE FLY STORIES

AZRX

AzurRx BioPharma

$3.51

-0.04 (-1.13%)

15:54
04/28/17
04/28
15:54
04/28/17
15:54
Hot Stocks
Breaking Hot Stocks news story on AzurRx BioPharma »

Matthew Balk reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMF

OneMain Holdings

$23.36

-1.26 (-5.12%)

15:51
04/28/17
04/28
15:51
04/28/17
15:51
Options
Opening action in OneMain Holdings puts as shares drop »

Opening action in OneMain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 25

    May

CHFC

Chemical Financial

$47.97

-0.79 (-1.62%)

15:50
04/28/17
04/28
15:50
04/28/17
15:50
Upgrade
Chemical Financial rating change  »

Chemical Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

BOFI

BofI Holding

$24.76

0.52 (2.15%)

15:46
04/28/17
04/28
15:46
04/28/17
15:46
Options
BofI Holding call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 30

    May

B

Barnes Group

$55.35

2.1 (3.94%)

15:43
04/28/17
04/28
15:43
04/28/17
15:43
Downgrade
Barnes Group rating change  »

Barnes Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

ADI

Analog Devices

$77.85

-0.13 (-0.17%)

15:36
04/28/17
04/28
15:36
04/28/17
15:36
Options
Analog Devices put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MDXG

MiMedx

$11.40

0.3 (2.70%)

15:32
04/28/17
04/28
15:32
04/28/17
15:32
Recommendations
MiMedx analyst commentary  »

MiMedx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 06

    Jun

GST

Gastar Exploration

$1.31

0.01 (0.77%)

15:30
04/28/17
04/28
15:30
04/28/17
15:30
Conference/Events
Gastar Exploration to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    May

CLVS

Clovis

$58.21

-0.43 (-0.73%)

15:26
04/28/17
04/28
15:26
04/28/17
15:26
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

$NSD

NASDAQ Market Internals

15:17
04/28/17
04/28
15:17
04/28/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIG

Fortress

$8.04

0.005 (0.06%)

, SFTBF

SoftBank

$75.60

0.71 (0.95%)

15:17
04/28/17
04/28
15:17
04/28/17
15:17
Periodicals
Fortress exploring sale of Logan Circle bond fund unit, Reuters says »

Fortress Investment Group…

FIG

Fortress

$8.04

0.005 (0.06%)

SFTBF

SoftBank

$75.60

0.71 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
04/28/17
04/28
15:16
04/28/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
04/28/17
04/28
15:15
04/28/17
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CAG

Conagra Brands

$38.82

0.005 (0.01%)

15:11
04/28/17
04/28
15:11
04/28/17
15:11
Options
Downside put buyer in Conagra Foods »

Downside put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$72.36

-0.78 (-1.07%)

15:10
04/28/17
04/28
15:10
04/28/17
15:10
Initiation
Cardinal Health initiated  »

Cardinal Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

FIG

Fortress

$8.04

0.01 (0.12%)

15:04
04/28/17
04/28
15:04
04/28/17
15:04
Periodicals
Breaking Periodicals news story on Fortress »

Fortress exploring sale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$9.06

0.03 (0.33%)

15:01
04/28/17
04/28
15:01
04/28/17
15:01
Options
Sprint calls active ahead of earnings next week »

Sprint calls active ahead…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

GME

GameStop

$22.80

-0.3 (-1.30%)

14:56
04/28/17
04/28
14:56
04/28/17
14:56
Options
GameStop put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 31

    May

BSX

Boston Scientific

$26.43

0.25 (0.95%)

14:55
04/28/17
04/28
14:55
04/28/17
14:55
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 07

    Jun

  • 27

    Jun

TKPYY

Takeda Pharmaceutical Co. Ltd.

$23.98

0.05 (0.21%)

14:51
04/28/17
04/28
14:51
04/28/17
14:51
Hot Stocks
FDA grants accelerated approval to Takeda's brigatinib »

On April 28, 2017, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$39.76

-0.34 (-0.85%)

14:48
04/28/17
04/28
14:48
04/28/17
14:48
Conference/Events
The Progressive Corporation to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVO

Cenveo

$4.39

0.095 (2.21%)

14:48
04/28/17
04/28
14:48
04/28/17
14:48
Hot Stocks
Breaking Hot Stocks news story on Cenveo »

Nathu Ram Puri reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

BMY

Bristol-Myers

$56.01

0.34 (0.61%)

14:42
04/28/17
04/28
14:42
04/28/17
14:42
Hot Stocks
Bristol-Myers announces European Commission approval of Opdivo »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 06

    Jun

TAP

Molson Coors

$95.84

0.06 (0.06%)

14:41
04/28/17
04/28
14:41
04/28/17
14:41
Conference/Events
Molson Coors to hold an earnings follow-up conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

IWM

iShares Trust Russell 2000 Index Fund

$139.37

-1.58 (-1.12%)

, RUT

Russell 2000 Index

14:40
04/28/17
04/28
14:40
04/28/17
14:40
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT)…

IWM

iShares Trust Russell 2000 Index Fund

$139.37

-1.58 (-1.12%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.